TY - JOUR
T1 - Focused Versus Bilateral Parathyroid Exploration for Primary Hyperparathyroidism
T2 - A Systematic Review and Meta-analysis
AU - Jinih, Marcel
AU - O’Connell, Emer
AU - O’Leary, Donal P.
AU - Liew, Aaron
AU - Redmond, Henry P.
N1 - Publisher Copyright:
© 2016, Society of Surgical Oncology.
PY - 2017/7/1
Y1 - 2017/7/1
N2 - Background: Focused exploration (FE) and bilateral parathyroid exploration (BE) are the standard surgical options for patients with primary hyperparathyroidism. However, the relative risk of recurrence, persistence, overall failure, reoperation, and any complications associated with either surgical approach is unclear. This study compared the outcomes and complication rates after FE and BE for patients with primary hyperparathyroidism. Methods: PubMed and Embase were searched for studies comparing these outcomes between FE and BE. A meta-analysis was performed using RevMan 5.3 software. Published data were pooled using the DerSimonian random-effect model, and results were presented as odds ratio (OR) or mean difference with 95% confidence interval (CI). Results: A total of 12,743 patients from 19 studies were included in this meta-analysis. In comparison with BE, the FE arm had comparable rates of recurrence (OR 1.08; 95% CI 0.59–2.00; p = 0.80; n = 9 studies), persistence (OR 0.89; 95% CI 0.58–1.35; p = 0.58; n = 13), overall failure (OR 0.88; 95% CI 0.58–1.34; p = 0.56; n = 13), and reoperation (OR 1.05; 95% CI 0.25–4.32; p = 0.95, n = 4). The operative time was significantly shorter (mean difference = −39.86; 95% CI −53.05 to −26.84; p < 0.01, n = 9), with a lower overall complication rate in the FE arm (OR 0.35; 95% CI 0.15–0.84; p = 0.02; n = 12). The latter was attributed predominantly to a lower risk of transient hypocalcemia (OR 0.36; 95% CI 0.14–0.90; p = 0.03; n = 9). There was a significant heterogeneity among these studies for all outcomes except for disease recurrence. Conclusions: Compared with BE, FE has similar recurrence, persistence, and reoperation rates but significantly lower overall complication rates and shorter operative time.
AB - Background: Focused exploration (FE) and bilateral parathyroid exploration (BE) are the standard surgical options for patients with primary hyperparathyroidism. However, the relative risk of recurrence, persistence, overall failure, reoperation, and any complications associated with either surgical approach is unclear. This study compared the outcomes and complication rates after FE and BE for patients with primary hyperparathyroidism. Methods: PubMed and Embase were searched for studies comparing these outcomes between FE and BE. A meta-analysis was performed using RevMan 5.3 software. Published data were pooled using the DerSimonian random-effect model, and results were presented as odds ratio (OR) or mean difference with 95% confidence interval (CI). Results: A total of 12,743 patients from 19 studies were included in this meta-analysis. In comparison with BE, the FE arm had comparable rates of recurrence (OR 1.08; 95% CI 0.59–2.00; p = 0.80; n = 9 studies), persistence (OR 0.89; 95% CI 0.58–1.35; p = 0.58; n = 13), overall failure (OR 0.88; 95% CI 0.58–1.34; p = 0.56; n = 13), and reoperation (OR 1.05; 95% CI 0.25–4.32; p = 0.95, n = 4). The operative time was significantly shorter (mean difference = −39.86; 95% CI −53.05 to −26.84; p < 0.01, n = 9), with a lower overall complication rate in the FE arm (OR 0.35; 95% CI 0.15–0.84; p = 0.02; n = 12). The latter was attributed predominantly to a lower risk of transient hypocalcemia (OR 0.36; 95% CI 0.14–0.90; p = 0.03; n = 9). There was a significant heterogeneity among these studies for all outcomes except for disease recurrence. Conclusions: Compared with BE, FE has similar recurrence, persistence, and reoperation rates but significantly lower overall complication rates and shorter operative time.
UR - https://www.scopus.com/pages/publications/84997822215
U2 - 10.1245/s10434-016-5694-1
DO - 10.1245/s10434-016-5694-1
M3 - Article
C2 - 27896505
AN - SCOPUS:84997822215
SN - 1068-9265
VL - 24
SP - 1924
EP - 1934
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
IS - 7
ER -